Last $2.06 USD
Change Today +0.095 / 4.85%
Volume 1.2M
BIOD On Other Exchanges
Symbol
Exchange
BIOD is not on other exchanges.
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

biodel inc (BIOD) Snapshot

Open
$1.97
Previous Close
$1.96
Day High
$2.08
Day Low
$1.96
52 Week High
08/5/13 - $6.08
52 Week Low
07/18/14 - $1.85
Market Cap
43.4M
Average Volume 10 Days
228.0K
EPS TTM
$-1.11
Shares Outstanding
21.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIODEL INC (BIOD)

Related News

No related news articles were found.

biodel inc (BIOD) Related Businessweek News

No Related Businessweek News Found

biodel inc (BIOD) Details

Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. It is involved in developing proprietary insulin formulations for type 1 and type 2 diabetes patients; ultra-rapid-acting insulin analog-based formulations; glucagon formulations and presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia or very low concentrations of blood glucose; and other recombinant human insulin-based formulations. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

35 Employees
Last Reported Date: 12/20/13
Founded in 2003

biodel inc (BIOD) Top Compensated Officers

Chief Executive Officer, President, Principal...
Total Annual Compensation: $677.9K
Chief Medical Officer
Total Annual Compensation: $427.3K
Compensation as of Fiscal Year 2013.

biodel inc (BIOD) Key Developments

Biodel Inc. Announces Resignation of Gerard Michel as Chief Financial Officer, Effective May 30, 2014

On May 19, 2014, Gerard Michel, the Chief Financial Officer of Biodel Inc. provided notice of his intention to resign from the company effective May 30, 2014. Effective as of May 30, 2014, Errol De Souza, the company’s President and Chief Executive Officer, will assume the role of principal financial officer until a replacement Chief Financial Officer is appointed.

Biodel Inc. Presents at JMP Securities Healthcare Conference, Jun-25-2014 12:00 PM

Biodel Inc. Presents at JMP Securities Healthcare Conference, Jun-25-2014 12:00 PM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States.

Biodel Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended March 31, 2014

Biodel Inc. reported unaudited consolidated earnings results for the second quarter and six months ended March 31, 2014. For the quarter, the company reported net loss of $6.2 million, or $0.29 per share of common stock, compared to a net loss of $5.2 million, or $0.37 per share of common stock, for the same period in the prior year. Loss before tax provision was $6,194,000 against $5,215,000 a year ago. For the six months, the company reported net loss of $8.6 million, or $0.41 per basic and diluted share of common stock, compared to a net loss of $8.8 million, or $0.63 per basic and diluted share of common stock, for the same period in the prior year. Loss before tax provision was $8,631,000 against $8,880,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOD:US $2.06 USD +0.095

BIOD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIOD.
View Industry Companies
 

Industry Analysis

BIOD

Industry Average

Valuation BIOD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIODEL INC, please visit www.biodel.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.